Solid, Steady Growth Forecast for Global Urinary Catheter Market

The world’s urinary catheter market is primed for a prosperous future.

Data from Kenneth Research indicates the sector will swell 5.83 percent annually through 2031 to reach $4.6 billion. Key growth drivers include increasing chronic kidney disease caseloads, higher numbers of surgical procedures and urinary incontinence diagnoses, and of course, the world’s aging population.   

Kidney diseases are a leading cause of death around globally. According to Institute for Health Metrics and Evaluation (IHME) statistics, the prevalence of chronic kidney disease worldwide increased from 559,268,790 cases in 2010 to 697,294,306 cases in 2019. Additionally, the disease killed 1,427,231 people in 2019, up from 1,108,207 victims nine years prior. Furthermore, the incidence of the disease grew from 14,180,547 cases to 18,986,903 cases during tha period.
 
The world’s geriatric population is rapidly increasing and so is the concern for different types of diseases. By the end of 2050, one in six people are expected to be over the age of 65, according to United Nations data. The organization’s statistics also show that one in 11 people were over the age of 65 in 2019. Most of the population is unable to live a normal life and often require medical or physical support to perform their daily activities, thereafter driving the need for products such as urinary catheters. On the other hand, the increasing cases of chronic kidney disease, which is driving the need for these catheters, are also expected to drive market growth. The global urinary catheters market generated $2.63 billion in revenue last year and is expected to reach $4.59 billion by the end of 2031.
 
The market growth can also be attributed to the increasing number of surgical procedures of different types of diseases along with the growing prevalence of urinary incontinence. For instance, according to statistics by the Organisation for Economic Co-Operation and Development (OECD), there were 45,398 total coronary artery bypass surgeries in Germany. Additionally, hip replacement surgeries and caesarian sections in the country grew from 232,126 cases and 206,746 cases, respectively, in 2010 to 261,675 cases and 230,348 cases, respectively, in 2019. Besides this, the surge in product development and increasing health expenditures globally is also expected to boost market growth in the coming years. The current health expenditure as a share of GDP touched 9.84 percent in 2019, up from 9.09 percent in 2008, according to the World Bank. 
 
The global urinary catheter market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Amongst the market in these regions, the market in North America generated the largest revenue of $1.16 billion last year and is projected to reach $2 billion by the end of 2031. The market’s growth in this region can primarily be attributed to the rising awareness about urinary catheters’ benefits and an increasing concern for urinary continence amongst the population. It has been estimated that in the United States, about 33 million people have overactive bladder (OAB), according to the statistics by the Urology Care Foundation, the official foundation of the American Urological Association. Moreover, the statistics also stated that a quarter to a third of the nation’s population suffered from urinary incontinence. In addition to this, the growing prevalence of chronic kidney diseases in North America is also estimated to boost the market’s growth. According to the statistics by the National Kidney Foundation, one in three adults in the United States was at risk for kidney disease. Moreover, the statistics also stated that an estimated 37 Million people were affected by kidney disease. The region’s market is further segmented by country into the United States and Canada. Amongst the market in these countries, the market in the United States is projected to attain the largest revenue by the end of 2031 and also grow with the highest annual rate of 5.68 percent during the forecast period.
 
The urinary catheter market in Europe registered the second-largest revenue of $675.75 million last year and is expected to reach $1.18 billion by the end of 2031. The market in the region is further segmented by country into Germany, United Kingdom, Italy, France, Spain, Russia, Netherlands, and the Rest of Europe. Among these countries, the German market is expected to generate the largest revenue of $256.5 million by the end of 2031, up from $140.8 million in 2021. France had the second-largest revenue for urinary catheters, generating $126.4 million last year. The French market is projected to reach $220.4 million by the end of 2031.
 
The global urinary catheter market is segmented on the basis of application into urinary incontinence, benign prostate hyperplasia & prostate surgeries, spinal cord injury, and others. Amongst these, the urinary incontinence segment registered the largest revenue of $1 billion last year and is projected to swell to $1.72 billion by the end of 2031. The North American market is projected to generate the largest revenue ($754.6 million by the end of 2031, up from $445.2 million in 2021). The U.S. market registered the largest revenue ($399.7 million in 2021) and is expected to reach $676.1 million by the end of 2031. Europe’s market is forecast to generate the largest revenue ($443.6 million by the end of 2031, up from $258.2 million in 2021).
 
On the other hand, the global urinary catheter market is segmented on the basis of end-user into hospitals, long term care facilities, and others. Amongst these, the hospitals segment registered the largest revenue (1.41 billion last year) and is estimated to reach $2.42 billion by the end of 2031. The North American market will garner the largest revenue ($1.05 billion by the end of 2031, up from $621.6 million last year). The U.S. market is projected to reach $943.9 million by the end of 2031, up from $557.02 million in 2021. The Asia Pacific sector is anticipated to grow 6.66 percent during the forecast period, generating $490.9 million by the end of 2031, up from $259.7 million last year.
 
Some companies in the global urinary catheter market include B. Braun Melsungen AG, Boston Scientific Corporation, Coloplast Group, ConvaTec Group plc, Becton, Dickinson and Company, Medtronic plc, Teleflex Incorporated, Wellspect Healthcare (Dentsply Sirona Group), BACTIGUARD AB, Hollister Incorporated, and Amsino International Inc.